Key result
Preincubating matrix with rTFPI, FVIIa, and FXa cuts fibrin deposition by ~91% versus control.
Why the study?
Does recombinant tissue factor pathway inhibitor prevent thrombus formation on procoagulant subendothelial matrix in a human ex vivo model?
Does recombinant tissue factor pathway inhibitor prevent thrombus formation on procoagulant subendothelial matrix in a human ex vivo model?
Answers are grounded in this paper and cite their sources.
Recombinant tissue factor pathway inhibitor, in a factor Xa-dependent manner, prevents thrombus formation on procoagulant extracellular matrix in an ex vivo model, suggesting potential as an antithrombotic agent.
The effect of recombinant tissue factor pathway inhibitor (rTFPI) on extracellular matrix procoagulant activity was studied in a human ex vivo model of thrombogenesis. Extracellular matrix of endotoxin stimulated endothelial cells perfused with human non-anticoagulated blood at a wall shear rate of 100/s induced pronounced fibrin deposition, which covered 82 +/- 11% of the matrix surface within 5 min. Preincubating the matrix with the combination of rTFPI, factor VIIa (FVIIa) and factor Xa (FXa) reduced fibrin deposition to levels observed with matrix from non-stimulated endothelial cells (7 +/- 6% fibrin coverage, P < 0.001). Preincubation with rTFPI plus FXa also reduced fibrin deposition significantly, but to a lesser extent (41 +/- 6% fibrin coverage, P < 0.001). Preincubation with rTFPI alone, or with rTFPI plus FVIIa, did not affect fibrin deposition. The inhibition of thrombus formation on procoagulant extracellular matrix by rTFPI seemed to be FXa-dependent, and a result of TFPI's ability to bind and inhibit both TF activity as well as FXa. The results from this study suggest a future role for rTFPI as an agent for prevention of TF-induced vascular thrombosis.
No takes yet. Share an insight, caveat, or question.
Lindahl et al. (1994) studied Thrombogenesis. recombinant tissue factor pathway inhibitor (rTFPI) with factor VIIa and factor Xa vs. endotoxin stimulated endothelial cells without preincubation was evaluated on Fibrin deposition (matrix surface coverage) (p=<0.001). Preincubating procoagulant extracellular matrix with rTFPI, factor VIIa, and factor Xa reduced fibrin deposition to 7% compared to 82% in the control matrix.
Synapse has enriched 10 related papers. Consider them for comparative context: